Diagnosing and managing post menopausal osteoporosis: opportunities for fracture prevention

Compr Ther. 2003 Summer-Fall;29(2-3):115-23. doi: 10.1007/s12019-003-0015-6.

Abstract

Osteoporosis is an asymptomatic disease until a fracture occurs. Management includes primary prevention, early detection through targeted screening, and implementation of appropriate treatment and monitoring strategies. This article explores these issues in depth.

Publication types

  • Review

MeSH terms

  • Absorptiometry, Photon
  • Bone Density / drug effects
  • Calcitonin / therapeutic use
  • Diphosphonates / therapeutic use
  • Estrogen Replacement Therapy
  • Female
  • Fractures, Bone / prevention & control
  • Humans
  • Osteoporosis, Postmenopausal* / diagnosis
  • Osteoporosis, Postmenopausal* / drug therapy
  • Osteoporosis, Postmenopausal* / prevention & control
  • Raloxifene Hydrochloride / therapeutic use
  • Risk Factors
  • Selective Estrogen Receptor Modulators / therapeutic use

Substances

  • Diphosphonates
  • Selective Estrogen Receptor Modulators
  • Raloxifene Hydrochloride
  • Calcitonin